Butyrate enhancement of inteleukin-1β production via activation of oxidative stress pathways in lipopolysaccharide-stimulated THP-1 cells

Journal of Clinical Biochemistry and Nutrition

Volumn 50, Issue 1, 2012, Pages 59-66

  Ohira, Hideo ^a,b   Fujioka, Yoshio ^a   Katagiri, Chikae ^a   Yano, Mayumi ^a   Mamoto, Rie ^a   Aoyama, Michiko ^b   Usami, Makoto ^b   Ikeda, Masamichi ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Butyrate; Caspase 1; Interleukin 1 (IL 1 ); Macrophage; Reactive oxygen species (ROS)

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; ACTIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BUTYRIC ACID; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PERTUSSIS TOXIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS;

EID: 84855382568     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-22     Document Type: Article

References (33)

1. Danese S, Fiocchi C. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol 2006; 12: 4807-4812. (Pubitemid 44323204)
2. Dionne S, Hiscott J, D'Agata I, Duhaime A, Seidman EG. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Dig Dis Sci 1997; 42: 1557-1566. (Pubitemid 27339380)
3. McAlindon ME, Hawkey CJ, Mahida YR. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut 1998; 42: 214-219. (Pubitemid 28212176)
4. Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 2003; 52: 79-83. (Pubitemid 36020770)
5. Eftimiadi C, Stashenko P, Tonetti M, et al. Divergent effect of the anaerobic bacteria by-product butyric acid on the immune response: suppression of Tlymphocyte proliferation and stimulation of interleukin-1 beta production. Oral Microbiol Immunol 1991; 6: 17-23.
6. Jung YD, Liu W, Reinmuth N, et al. Vascular endothelial growth factor is upregulated by interleukin-1 beta in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway. Angiogenesis 2001; 4: 155-162. (Pubitemid 34032701)
7. Fujioka Y, Cooper AD, Fong LG. Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages. J Lipid Res 1998; 39: 2339-2349. (Pubitemid 29006297)
8. Okumura T, Fujioka Y, Morimoto S, et al. Chylomicron remnants stimulate release of interleukin-1beta by THP-1 cells. J Atheroscler Thromb 2006; 13: 38-45.
9. Kamemura K, Fujioka Y, Takaishi H, et al. Chylomicron remnants upregulate CD40 expression via the ERK pathway and a redox-sensitive mechanism in THP-1 cells. Atherosclerosis 2006; 187: 257-264. (Pubitemid 43963011)
10. Hirasawa A, Hara T, Katsuma S, Adachi T, Tsujimoto G. Free fatty acid receptors and drug discovery. Biol Pharm Bull 2008; 31: 1847-1851.
11. Le Poul E, Loison C, Struyf S, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 2003; 278: 25481-25489. (Pubitemid 36835299)
12. Sanborn BM, Ku CY, Shlykov S, Babich L. Molecular signaling through G-protein-coupled receptors and the control of intracellular calcium in myometrium. J Soc Gynecol Investig 2005; 12: 479-487. (Pubitemid 41395236)
13. Radeff-Huang J, Seasholtz TM, Matteo RG, Brown JH. G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival. J Cell Biochem 2004; 92: 949-966. (Pubitemid 44264244)
14. Parsons SJ, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene 2004; 23: 7906-7909. (Pubitemid 39468849)
15. Park JB. Phagocytosis induces superoxide formation and apoptosis in macrophages. Exp Mol Med 2003; 35: 325-335.
16. Forman HJ, Torres M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 2002; 166: S4-S8 . (Pubitemid 36015930)
17. Fubini B, Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in Inflammation and fibrosis. Free Radic Biol Med 2003; 34: 1507-1516. (Pubitemid 36638711)
18. Miller DK, Myerson J, Becker JW. The interleukin-1 beta converting enzyme family of cysteine proteases. J Cell Biochem 1997; 64: 2-10. (Pubitemid 27081789)
19. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001; 81: 1031-1064. (Pubitemid 32611227)
20. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28: 1221-1227. (Pubitemid 17156038)
21. Heerdt BG, Houston MA, Augenlicht LH. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res 1994; 54: 3288-3293.
22. Andoh A, Tsujikawa T, Fujiyama Y. Role of dietary fiber and short-chain fatty acids in the colon. Current Pharm Design 2003; 9: 347-358. (Pubitemid 36131728)
23. Gibson P, Rosella O. Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut 1995; 37: 536-543.
24. Ohno Y, Lee J, Fusunyan RD, MacDermott RP, Sanderson IR. Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells. Proc Natl Acad Sci USA 1997; 94: 10279-10284. (Pubitemid 27407032)
25. Segain JP, Raingeard de la Blétière D, Bourreille A, et al. Butyrate inhibits inflammatory responses through NFkappa B inhibition: implications for Crohn's disease. Gut 2000; 47: 397-403.
26. Park JS, Lee EJ, Lee JC, Kim WK, Kim HS. Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappa B and ERK signaling pathways. Int Immunopharmacol 2007; 7: 70-77.
27. Yin L, Laevsky G, Giardina C. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem 2001; 276: 44641-44646.
28. Lührs H, Gerke T, Schauber J, et al. Cytokine-activated degradation of inhibitory kappaB protein alpha is inhibited by the short-chain fatty acid butyrate. Int J Colorectal Dis 2001; 16: 195-201. (Pubitemid 32700694)
29. Steinhart AH, Hiruki T, Brzezinski A, Baker JP. Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment Pharmacol Ther 1996; 10: 729-736. (Pubitemid 26340202)
30. Breuer RI, Soergel KH, Lashner BA, et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut 1997; 40: 485-491. (Pubitemid 27204928)
31. ten Hove T, van den Blink B, Pronk I, Drillenburg P, Peppelenbosch MP, van Deventer SJ. Dichotomal role of inhibition of p38 MAPK with SB203580 in experimental colitis. Gut 2002; 50: 507-512. (Pubitemid 34638870)
32. Jaffee BD, Manos EJ, Collins RJ, et al. Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo. Biochem Biophys Res Commun 2000; 268: 647-651. (Pubitemid 30119676)
33. Coogan AN, O'Neill LA, O'Connor JJ. The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1 beta on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 1999; 93: 57-69. (Pubitemid 29290686)